FDA Biologics (BLA & Biosimilars)Original article
2022 Center for Biologics Evaluation and Research (CBER) Science Symposium - 09/20/2022
ConferenceNeutral
AI Analysis
Summary
The FDA's Center for Biologics Evaluation and Research (CBER) held a science symposium on September 20, 2022 to discuss scientific topics related to the regulation of biologics, featuring presentations from academic institutions, government agencies, and research institutions.
Importance:1/10
Sentiment:
0.00
conferenceFDACBERregulatory sciencebiologics
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 15, 2026 3:38 PM